These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 7197541

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Penetration and antifungal activity of ciclopiroxolamine in hornified tissue (author's transl)].
    Dittmar W.
    Arzneimittelforschung; 1981; 31(8A):1353-9. PubMed ID: 7197542
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.
    Jue SG, Dawson GW, Brogden RN.
    Drugs; 1985 Apr; 29(4):330-41. PubMed ID: 3158508
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR, Mayo BC, Chasseaud LF, Hawkins DR.
    Arzneimittelforschung; 1977 Apr; 27(3):593-8. PubMed ID: 577426
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic studies following systemic and topical administration of [14C]bifonazole in man.
    Patzschke K, Ritter W, Siefert HM, Weber H, Wegner LA.
    Arzneimittelforschung; 1983 Apr; 33(5):745-50. PubMed ID: 6683553
    [Abstract] [Full Text] [Related]

  • 13. HPLC method for pharmacokinetic studies on ciclopirox olamine in rabbits after intravenous and intravaginal administrations.
    Coppi G, Silingardi S.
    Farmaco; 1992 May; 47(5 Suppl):779-86. PubMed ID: 1524626
    [Abstract] [Full Text] [Related]

  • 14. The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy.
    Weir SJ, Patton L, Castle K, Rajewski L, Kasper J, Schimmer AD.
    J Clin Pharm Ther; 2011 Apr; 36(2):128-34. PubMed ID: 21366640
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H, Sugimoto T, Ago M, Morino A.
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of Ciclopirox Olamine after Buccal Administration in Rabbits.
    Lukášová I, Muselík J, Vetchý D, Gajdziok J, Gajdošová M, Juřica J, Knotek Z, Hauptman K, Jekl V.
    Curr Drug Deliv; 2017 Nov; 14(1):99-108. PubMed ID: 27138296
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.